Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

The New York Times – Business:

Concerns that well-funded Chinese companies will swoop in to grab new ideas for their own drug development are shaping an industry unaccustomed to such secrecy.

Gina Kolata
Author: Gina Kolata

This post first appeared in The New York Times – Business. Read the original article.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *